2160-52-3Relevant articles and documents
Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides
Chan, Laval,Das, Sanjoy K.,Reddy, T. Jagadeeswar,Poisson, Carl,Proulx, Melanie,Pereira, Oswy,Courchesne, Marc,Roy, Caroline,Wang, Wuyi,Siddiqui, Arshad,Yannopoulos, Constantin G.,Nguyen-Ba, Nghe,Labrecque, Denis,Bethell, Richard,Hamel, Martine,Courtemanche-Asselin, Philippe,L'Heureux, Lucille,David, Maud,Nicolas, Olivier,Brunette, Stephanie,Bilimoria, Darius,Bedard, Jean
, p. 793 - 796 (2004)
The discovery of a novel class of HCV NS5B polymerase inhibitors, 3-arylsulfonylamino-5-phenyl-thiophene-2-carboxylic acids is described. SAR studies have yielded several potent inhibitors of HCV polymerase as well as of HCV subgenomic RNA replication in
DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS
-
Page/Page column 70, (2014/01/08)
The invention relates to inhibitors of the phosphodiesterase 4 (PDE4) enzyme. More particularly, the invention relates to compounds that are derivatives of 1 -phenyl-2-pyridinyl alkyl alcohols, methods of preparing such compounds, compositions containing them and therapeutic use thereof.